Place of mTOR inhibitors in management of BKV infection after kidney transplantation
Context: BK virus (BKV) viremia and BKV-associated nephropathy (BKVAN) have become a serious nuisance to kidney transplant (KT) patients since the mid-nineties, when the incidence of this disease has increased significantly.
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790181/ |